Nrf2激活是减轻糖尿病视网膜病变的潜在治疗方法
本研究在大鼠糖尿病模型和体外高糖培养的Müller细胞中,评估新型Nrf2激活剂dh404对糖尿病视网膜病变的保护作用。结果显示dh404可减少视网膜血管渗漏、降低VEGF、血管生成素-2、TNF-α和IL-6等因子,保护Müller细胞并增强视网膜抗氧化能力。作者认为dh404可能保护视网膜免受糖尿病损伤并可能预防视力丧失。
要点
- dh404可防止糖尿病大鼠视网膜和玻璃体腔的血管渗漏。
- dh404降低VEGF、血管生成素-2、TNF-α和IL-6等因子。
- dh404保护Müller细胞并增强视网膜抗氧化能力。
核心结论
- 数据表明dh404能够保护视网膜免受糖尿病诱导的损伤,并可能预防视力丧失。
研究设计与样本
- Sprague-Dawley大鼠随机分为糖尿病组和非糖尿病组,灌胃给予dh404共10周。
- 在体外培养的Müller细胞中进行高糖暴露的补充研究。
主要发现
- 在糖尿病中,dh404防止血管渗漏进入视网膜和玻璃体腔,并防止血管通透性和血管生成因子VEGF和血管生成素-2以及炎症介质TNF-α和IL-6的上调。
- 糖尿病中Müller细胞发生胶质增生伴胶质纤维酸性蛋白免疫标记增加,dh404对其产生保护。
- 糖尿病中dh404增强视网膜抗氧化能力,增加血红素加氧酶-1、NADH/NADPH醌氧化还原酶-1和Nrf2。
- dh404减轻糖尿病诱导的氧化应激增加,以二氢乙锭和8-氧代-2'-脱氧鸟苷免疫标记以及NADPH氧化酶同工型表达衡量。
- Müller细胞研究支持这些发现,dh404减轻高糖诱导的血管通透性、血管生成和炎症介质以及氧化应激的增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oxidative stress is a causal factor in the development of diabetic retinopathy; however, clinically relevant strategies to treat the disease by augmenting antioxidant defense mechanisms have not been fully explored. We hypothesized that boosting nuclear factor erythroid-2-related factor 2 (Nrf2) antioxidant capacity with the novel Nrf2 activator dh404, would protect the retina in diabetes including vision-threatening breakdown of the blood-retinal barrier (BRB) and associated damage to macroglial Müller cells. METHODS: Sprague-Dawley rats were randomized to become diabetic or nondiabetic and administered dh404 by gavage for 10 weeks. Complementary in vitro studies were performed in cultured Müller cells exposed to hyperglycemia. RESULTS: In diabetes, dh404 prevented vascular leakage into the retina and vitreous cavity as well as upregulation of the vascular permeability and angiogenic factors, VEGF, and angiopoietin-2, and inflammatory mediators, including TNF-α and IL-6. Müller cells, which maintain BRB integrity and become gliotic in diabetes with increased immunolabeling for glial fibrillary acidic protein, were protected by dh404. In diabetes, dh404 bolstered the antioxidant capacity of the retina with an increase in hemeoxygenase-1, nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) quinine oxidoreductase-1, and Nrf2. Further, dh404 attenuated the diabetes-induced increase in oxidative stress as measured by dihydroethidium and 8-oxo-2'-deoxyguanosine (8-OHdG) immunolabeling as well as NADPH oxidase isoform expression. Studies in Müller cells supported these findings with dh404 attenuating the hyperglycemia-induced increase in vascular permeability, angiogenic and inflammatory mediators, and oxidative stress. CONCLUSIONS: Our data demonstrate the ability of dh404 to protect the retina against diabetes-induced damage and potentially prevent vision loss.
引用
- Deliyanti D, Alrashdi SF, Tan SM, et al. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2018. PMID: 29411009. doi:10.1167/iovs.17-22920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。